Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis

Completed

• Conditions: Sepsis

• Registration Number: NCT01362504
• Lead Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital

Brief Summary

The aim of this study was to clarify the prognostic value of serum pro-Adrenomedullin level in neonatal sepsis. Eighty term and preterm neonates with sepsis were enrolled in this study. Eighty healthy matched neonates served as a control group.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-05
• Study First Submitted: 2011-05-26
• Study First Submitted QC: 2011-05-27
• Study First Posted: 2011-05-30
• Primary Completion: 2011-08
• Study Completion: 2011-09
• Status Verified: 2011-10
• Last Update Submitted: 2011-10-07
• Last Update Posted: 2011-10-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Clinical sepsis and/or proven sepsis.

Exclusion Criteria

• Acute kidney injury
• Intracranial hemorrhage (Grade III and IV)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Zekai Tahir Burak Maternity Teaching Hospital, Neonatology Unit; 🇹🇷 Ankara, Turkey